Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

Primary biliary cholangitis has the highest waitlist mortality in patients with cirrhosis and acute on chronic liver failure awaiting liver transplant

Singal AK, Wong RJ, Jalan R, Asrani S, Kuo YF.

Clin Transplant 2021, 35(12): e14479

DOI: 10.1111/ctr.14479

Variceal bleeding has increased mortality compared to nonvariceal bleeding only in males

Erasmus HP, Bektas R, Orland K, Trifonova S, Gu WY, Uschner FE, Brol MJ, Chang J, Praktiknjo M, Strassburg CP, Trebicka J, Jansen C.

Eur J Gastroenterol Hepatol 2021, 33(1S Suppl 1): e94–e101

DOI: 10.1097/MEG.0000000000001964

Mitochondrial dysfunction in advanced liver disease: Emerging concepts

Zhang IW, López-Vicario C, Duran-Güell M, Clària J.

Front Mol Biosci 2021, 8: 772174

DOI: 10.3389/fmolb.2021.772174

Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018).

Gu W, Hortlik H, Erasmus HP, Schaaf L, Zeleke Y, Uschner FE, Ferstl P, Schulz M, Peiffer KH, Queck A, Sauerbruch T, Brol MJ, Rohde G, Sanchez C, Moreau R, Arroyo V, Zeuzem S, Welsch C, Trebicka J.

Lancet Reg Health Eur 2021, 12: 100240

DOI: 10.1016/j.lanepe.2021.100240

‘Equity’ and ‘justice’ for patients with acute-on chronic liver failure: A call to action

Jalan R, Gustot T, Fernandez J, Bernal W.

J Hepatol 2021, 75(5): 1228-1235

DOI: 10.1016/j.jhep.2021.06.017

Proresolving lipid mediators and liver disease

Clària J, Flores-Costa R, Duran-Güell M, López-Vicario C.

Biochim Biophys Acta Mol Cell Biol Lipids 2021, 1866(11): 159023

DOI: 10.1016/j.bbalip.2021.159023

Untargeted lipidomics uncovers lipid signatures that distinguish severe from moderate forms of acutely decompensated cirrhosis

Clària J, Curto A, Moreau R, Colsch B, López-Vicario C, Lozano JJ, Aguilar F, Castelli FA, Fenaille F, Junot C, Zhang I, Vinaixa M, Yanes O, Caraceni P, Trebicka J, Fernández J, Angeli P, Jalan R, Arroyo V.

J Hepatol 2021, 75(5): 1116–1127

DOI: 10.1016/j.jhep.2021.06.043

Immunosuppression and increased risk of bacterial infections in cirrhosis

Moreau R, Arroyo V.

IMD 2021, 3(3): 115–116

DOI: 10.1097/IM9.0000000000000073

Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

Belli LS, Duvoux C, Artzner T, Bernal W, Conti S, Cortesi PA, Sacleux SC, Pageaux GP, Radenne S, Trebicka J, Fernandez J, Perricone G, Piano S, Nadalin S, Morelli MC, Martini S, Polak WG, Zieniewicz K, Toso C, Berenguer M, Iegri C, Invernizzi F, Volpes R, Karam V, Adam R, Faitot F, Rabinovich L, Saliba F, Meunier L, Lesurtel M, Uschner FE, Fondevila C, Michard B, Coilly A, Meszaros M, Poinsot D, Schnitzbauer A, De Carlis LG, Fumagalli R, Angeli P, Arroyo V, Jalan R; ELITA/EF-CLIF working group.

J Hepatol 2021, 75(3): 610–622

DOI: 10.1016/j.jhep.2021.03.030

The use of rifaximin in patients with cirrhosis

Caraceni P, Vargas V, Solà E, Alessandria C, de Wit K, Trebicka J, Angeli P, Mookerjee RP, Durand F, Pose E, Krag A, Bajaj JS, Beuers U, Ginès P; Liverhope Consortium.

Hepatology 2021, 74(3): 1660–1673

DOI: 10.1002/hep.31708